Document Detail


The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma.
MedLine Citation:
PMID:  15108036     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recently, there has been increasing interest in treating intraocular retinoblastoma with systemic chemotherapy combined with focal laser therapy and cryotherapy instead of radiotherapy. We developed a system of selective ophthalmic arterial infusion (SOAI) therapy, administering melphalan, the agent which had the greatest effect on retinoblastoma in a clonogenic assay. The SOAI system consists of a combination of a micro-balloon, a guiding catheter, and a flushing hub. After selective catheterization to the cervical segment of the internal carotid artery by the guiding catheter, the micro-balloon was propelled to the portion just distal to the orifice of the ophthalmic artery. During temporary occlusion of the internal carotid artery, melphalan was infused from the introduced catheter tip. We treated 187 patients with intraocular retinoblastoma with SOAI; 563 SOAIs were performed for 610 eyes. The technical success rate was 97.51%. Fourteen examinations failed. No significant complication due to catheterization (including brain infarction) was detected. SOAI, using the balloon occlusion technique, is safe, and its use will prevent the side effects that occur with systemic chemotherapy, and eliminate the need for irradiation and enucleation.
Authors:
Takashi Yamane; Akihiro Kaneko; Makoto Mohri
Related Documents :
4068756 - Right ventricular balloon pumping.
11717666 - Arterial balloon occlusion of the hypogastric arteries: a life-saving procedure for sev...
2964146 - Dilatation balloons: polymer selection, balloon design and assembly.
17658026 - New technique for endoscopic removal of intragastric balloon placed for treatment of mo...
17592426 - The stiffness of normal and abnormal mitral valves.
8264056 - Long-term follow-up of patients undergoing reoperation for recurrent carotid artery dis...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of clinical oncology / Japan Society of Clinical Oncology     Volume:  9     ISSN:  1341-9625     ISO Abbreviation:  Int. J. Clin. Oncol.     Publication Date:  2004 Apr 
Date Detail:
Created Date:  2004-04-26     Completed Date:  2004-07-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9616295     Medline TA:  Int J Clin Oncol     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  69-73     Citation Subset:  IM    
Affiliation:
Department of Radiology, Saiseikai Kanagawa-ken Hospital, 6-6 Tomiya-cho, Kanagawa-ku, 221-8601, Yokohama, Japan. joecool@lares.dti.ne.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents, Alkylating / administration & dosage*
Child
Child, Preschool
Female
Humans
Infant
Infusions, Intra-Arterial* / instrumentation
Male
Melphalan / administration & dosage*
Ophthalmic Artery*
Retinal Neoplasms / drug therapy*
Retinoblastoma / drug therapy*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antineoplastic Agents, Alkylating; 148-82-3/Melphalan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of Scots pine seedling roots as an experimental model to investigate gene expression during inte...
Next Document:  Clinical efficacy of 123I-IMP SPECT for the diagnosis of malignant uveal melanoma.